Schizophrenia Trial, Recruiting NCT04945278 Sponsor: University Hospital, Brest Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT04945278
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • People aged between 15 and 25 years old
  • People who meet specific "Ultra High Risk" criteria as assessed using recognised clinical tools (confirm with trial site)
  • People who are willing to sign a consent form — for those under 18, a parent or guardian must also sign
  • People who are covered by a social security scheme (confirm with trial site for applicable countries)

For healthy volunteers:

  • People aged between 15 and 25 years old
  • People who do not personally know the patient they are being matched with in the study
  • People who are willing to sign a consent form — for those under 18, a parent or guardian must also sign
  • People who are covered by a social security scheme (confirm with trial site for applicable countries)

Who may not be able to join:

  • People with a history of epilepsy and/or migraines, due to the use of light stimuli in the study
  • Minors who do not wish to participate, even if their parent or legal guardian has agreed
  • People who experience claustrophobia (fear of enclosed spaces)
  • People who wear glasses (note: contact lenses may be acceptable — confirm with trial site)
  • People who do not have normal vision in both eyes without contact lenses
  • People who have distinctive or permanent markings on their face that cannot be temporarily removed
  • People who are under legal guardianship or who are not free to make their own decisions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nathalie LAVENNE, CHRU BREST

Phone: 02 98 01 50 46

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Brest
Registry
ClinicalTrials.gov
Start date
31 May 2022
Est. completion
31 July 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Average of the three M1

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov